Search Results for: RIGHTS MANAGEMENT PROTECTION You Have
Articles
June 1, 2016
RIGHTS MANAGEMENT PROTECTION - You Have the Right to Remain Protected June 1, 2016
Tom Johnson says on the surface, rights management protection may look like another expense and another system to maintain, and while that may be true, it is a critical security component that delivers rapid and significant return on investment.
June 29, 2020
Artelo Biosciences Expands Stony Brook Commercial License Agreement for Development of Lead Cancer, Pain & Inflammation Compounds June 29, 2020
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today...
April 2, 2018
FDA UPDATE - The FDA's New Drug Approval Process: Development & Premarket Applications April 2, 2018
Kaiser J. Aziz, PhD, in this latest FDA update, emphasizes quality system approaches to the development and availability of new drug information presented in the proposed labeling of the product.
October 4, 2015
Patently Disruptive October 4, 2015
Derek Hennecke, CEO &President of Xcelience, says Kyle Bass and his hedge fund are challenging pharma patents for the purpose of shorting their stocks and making a fortune and asks is this just industry noise or a true disruption?
October 11, 2012
10/16/2012 October 11, 2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license...
May 14, 2012
5/16/2012 May 14, 2012
Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...
March 7, 2012
3/13/2012 March 7, 2012
Aegerion Pharmaceuticals Submits US & EU Marketing Applications Aegerion Pharmaceuticals, Inc. recently announced it has submitted an NDA to the...
March 7, 2012
Particle Sciences Acquires Exclusive License to Lyotropic Therapeutics' Delivery Technology March 7, 2012
Particle Sciences, Inc. (PSI) and Lyotropics Therapeutics, Inc. recently announced PSI has acquired the exclusive rights to the Lyotropics' LyoCell...
February 12, 2012
2/14/2012 February 12, 2012
Bend Research Signs License Agreement With Eli Lilly & Company Bend Research Inc., a leading independent drug formulation development and...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
